Meeting report: First international conference on Crimean-Congo hemorrhagic fever

Antiviral Research

Volumn 120, Issue , 2015, Pages 57-65

  Papa, Anna ^a   Weber, Friedemann ^b   Hewson, Roger ^c   Weidmann, Manfred ^d   Koksal, Iftihar ^e   Korukluoglu, Gulay ^f   Mirazimi, Ali ^g  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF STIRLING   (United Kingdom)

^e KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^f Public Dental Health Center   (Turkey)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arbovirus; Crimean Congo hemorrhagic fever; Viral hemorrhagic fever; Zoonosis

Indexed keywords

AFRICA; ARTICLE; BALKAN PENINSULA; CHINA; CLINICAL FEATURE; CRIMEAN CONGO HEMORRHAGIC FEVER; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; DIAGNOSTIC PROCEDURE; ENDEMIC DISEASE; HUMAN; INCIDENCE; INDIA; IRAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCIENTIST; TICK BORNE DISEASE; TURKEY (REPUBLIC); VIRUS CELL INTERACTION; ASIA; COMMUNICABLE DISEASE CONTROL; EUROPE; HEMORRHAGIC FEVER, CRIMEAN; NAIROVIRUS; PATHOGENICITY; PHYSIOLOGY; PROCEDURES; VIROLOGY;

ARBOVIRUS; IXODIDA;

AFRICA; ASIA; COMMUNICABLE DISEASE CONTROL; EUROPE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INCIDENCE;

EID: 84930198119     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.05.005     Document Type: Review

References (36)

1. A. Antoniadis, S. Alexiou-Daniel, N. Malisiovas, I. Doutsos, T. Polyzoni, J.W. Leduc, C.J. Peters, and G. Saviolakis Seroepidemiological survey for antibodies to arboviruses in Greece Arch. Virol. Suppl. 1 1990 277 285
2. D.A. Bente, J.B. Alimonti, W.J. Shieh, G. Camus, U. Stroher, S. Zaki, and S.M. Jones Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model J. Virol. 84 21 2010 11089 11100
3. D.A. Bente, N.L. Forrester, D.M. Watts, A.J. McAuley, C.M. Whitehouse, and M. Bray Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity Antiviral Res. 100 2013 159 189
4. S. Bereczky, G. Lindegren, H. Karlberg, S. Akerstrom, J. Klingstrom, and A. Mirazimi Crimean Congo haemorrhagic fever virus infection is lethal for adult 1 type I interferon receptor knock-out mice J. Gen. Virol. 91 2010 1473 1477
5. E. Bergeron, C.G. Albarino, M.L. Khristova, and S.T. Nichol Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function J. Virol. 84 1 2010 216 226
6. E. Brisse, C.H. Wouters, and P. Matthys Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders Cytokine Growth Factor Rev. 2014
7. K.R. Buttigieg, S.D. Dowall, S. Findlay-Wilson, A. Miloszewska, E. Rayner, R. Hewson, and M.W. Carroll A novel vaccine against Crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model PLoS One 9 3 2014 e91516
8. A.M. Connolly-Andersen, I. Douagi, A.A. Kraus, and A. Mirazimi Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells Virology 390 2 2009 157 162
9. A.M. Connolly-Andersen, G. Moll, C. Andersson, S. Akerstrom, H. Karlberg, I. Douagi, and A. Mirazimi Crimean-Congo hemorrhagic fever virus activates endothelial cells J. Virol. 85 15 2011 7766 7774
10. S. Devignot, E. Bergeron, S. Nichol, A. Mirazimi, and F. Weber A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus J. Virol. 89 11 2015 5957 5967
11. N. Elaldi, H. Bodur, S. Ascioglu, A. Celikbas, Z. Ozkurt, H. Vahaboglu, H. Leblebicioglu, N. Yilmaz, A. Engin, M. Sencan, K. Aydin, I. Dokmetas, M.A. Cevik, B. Dokuzoguz, M.A. Tasyaran, R. Ozturk, M. Bakir, and R. Uzun Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey J. Infect. 58 3 2009 238 244
12. O. Ergonul Crimean-Congo haemorrhagic fever Lancet Infect. Dis. 6 4 2006 203 214
13. O. Ergonul Treatment of Crimean-Congo hemorrhagic fever Antiviral Res. 78 1 2008 125 131
14. O. Ergonul DEBATE (see Elaldi N et al., Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever J. Infect. 59 4 2009 284 286 (author reply 286-289)
15. O. Ergonul, A. Celikbas, B. Dokuzoguz, S. Eren, N. Baykam, and H. Esener Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy Clin. Infect. Dis. 39 2 2004 284 287
16. C. Escadafal, S. Olschlager, T. Avsic-Zupanc, A. Papa, J. Vanhomwegen, R. Wolfel, A. Mirazimi, A. Teichmann, O. Donoso-Mantke, and M. Niedrig First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus PLoS Negl. Trop. Dis. 6 6 2012 e1706
17. A. Estrada-Pena, Z. Zatansever, A. Gargili, M. Aktas, R. Uzun, O. Ergonul, and F. Jongejan Modeling the spatial distribution of Crimean-Congo hemorrhagic fever outbreaks in Turkey Vector Borne Zoonotic Dis. 7 4 2007 667 678
18. M.D. Fernandez-Garcia, A. Negredo, A. Papa, O. Donoso-Mantke, M. Niedrig, H. Zeller, A. Tenorio, L. Franco, and M. Enivd European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever, 2012 Euro Surveill. 19 26 2014
19. D. Goedhals, P.A. Bester, J.T. Paweska, R. Swanepoel, and F.J. Burt Comparative analysis of the L, M, and S RNA segments of Crimean-Congo haemorrhagic fever virus isolates from southern Africa J. Med. Virol. 87 5 2015 717 724
20. R. Guner, I. Hasanoglu, M.A. Tasyaran, D. Yapar, S. Keske, T. Guven, and G.R. Yilmaz Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever? Vector Borne Zoonotic Dis. 14 8 2014 601 605
21. H. Karlberg, G. Lindegren, and A. Mirazimi Comparison of antiviral activity of recombinant and natural interferons against Crimean-Congo hemorrhagic Fever virus Open Virol. J. 4 2010 38 41
22. H. Karlberg, Y.J. Tan, and A. Mirazimi Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection J. Biol. Chem. 286 5 2011 3227 3234
23. H. Karlberg, Y.J. Tan, and A. Mirazimi Crimean-Congo haemorrhagic fever replication interplays with regulation mechanisms of apoptosis J. Gen. Virol. 96 Pt 3 2015 538 546
24. S.S. Karti, Z. Odabasi, V. Korten, M. Yilmaz, M. Sonmez, R. Caylan, E. Akdogan, N. Eren, I. Koksal, E. Ovali, B.R. Erickson, M.J. Vincent, S.T. Nichol, J.A. Comer, P.E. Rollin, and T.G. Ksiazek Crimean-Congo hemorrhagic fever in Turkey Emerg. Infect. Dis. 10 8 2004 1379 1384
25. C. Klemm, J. Reguera, S. Cusack, F. Zielecki, G. Kochs, and F. Weber Systems to establish bunyavirus genome replication in the absence of transcription J. Virol. 87 14 2013 8205 8212
26. I. Koksal, G. Yilmaz, F. Aksoy, H. Aydin, I. Yavuz, S. Iskender, K. Akcay, S. Erensoy, R. Caylan, and K. Aydin The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey J. Clin. Virol. 47 1 2010 65 68
27. E.R. Mackow, E.E. Gorbunova, and I.N. Gavrilovskaya Endothelial cell dysfunction in viral hemorrhage and edema Front. Microbiol. 5 2014 733
28. M. Mardani, M.K. Jahromi, K.H. Naieni, and M. Zeinali The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran Clin. Infect. Dis. 36 12 2003 1613 1618
29. B. Morin, B. Coutard, M. Lelke, F. Ferron, R. Kerber, S. Jamal, A. Frangeul, C. Baronti, R. Charrel, X. de Lamballerie, C. Vonrhein, J. Lescar, G. Bricogne, S. Gunther, and B. Canard The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription PLoS Pathog. 6 9 2010 e1001038
30. S.B. Ozbey, C. Kader, A. Erbay, and O. Ergonul Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever Vector Borne Zoonotic Dis. 14 4 2014 300 302
31. A. Papa, I. Chaligiannis, N. Kontana, T. Sourba, K. Tsioka, A. Tsatsaris, and S. Sotiraki A novel AP92-like Crimean-Congo hemorrhagic fever virus strain, Greece Ticks Tick Borne Dis. 5 5 2014 590 593
32. O. Papadopoulos, and G. Koptopoulos Crimean-Congo hemorrhagic fever (CCHF) in Greece: isolation of the virus from Rhipicephalus bursa ticks and a preliminary serological survey V.-H. Jea, Arboviruses in the Mediterranean Countries 1980 Gustav Fisher Verlag Stuttgart, Yugoslavia 117 121
33. ProMED-mail, 2015. Ebola Update (09): WHO, Suitcase Diagnostic Lab, Suspected. Archive Number: 20150109.3082431. < http://kjbc.promedmail.org/direct.php?id=20150109.3082431 >.
34. B. Sharifi-Mood, M. Metanat, A. Ghorbani-Vaghei, F. Fayyaz-Jahani, and E. Akrami The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study Arch. Iran Med. 12 2 2009 151 153
35. D.M. Watts, M.A. Ussery, D. Nash, and C.J. Peters Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin Am. J. Trop. Med. Hyg. 41 5 1989 581 585
36. G. Zehender, E. Ebranati, R. Shkjezi, A. Papa, C. Luzzago, E. Gabanelli, A. Lo Presti, A. Lai, G. Rezza, M. Galli, S. Bino, and M. Ciccozzi Bayesian phylogeography of Crimean-Congo hemorrhagic fever virus in Europe PLoS One 8 11 2013 e79663